Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction

Akgul, Ozgur; Baycan, Omer; Bulut, Umit; Somuncu, Mustafa; Pusuroglu, Hamdi; Ozyilmaz, Sinem; Gul, Mehmet; Demir, Ali; Yilmaz, Emre; Yazan, Serkan; Kokturk, Ugur; Cetin, Ilyas; Uyarel, Huseyin

doi:10.1097/mca.0000000000000280

Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction

Akgul O., Baycan O. F., Bulut U., Somuncu M. U., Pusuroglu H., Ozyilmaz S., ...Daha Fazla

CORONARY ARTERY DISEASE, cilt.26, sa.7, ss.592-597, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 7
Basım Tarihi: 2015
Doi Numarası: 10.1097/mca.0000000000000280
Dergi Adı: CORONARY ARTERY DISEASE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.592-597
Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Objectives The prognostic value of pentraxin 3 (PTX3) has been documented in patients with acute coronary syndrome. However, its long-term prognostic value in acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the prognostic value of PTX3 in patients with STEMI undergoing a primary percutaneous coronary intervention (PCI).